Bruno Lococo

1.2k total citations
13 papers, 960 citations indexed

About

Bruno Lococo is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Organic Chemistry. According to data from OpenAlex, Bruno Lococo has authored 13 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Public Health, Environmental and Occupational Health and 3 papers in Organic Chemistry. Recurrent topics in Bruno Lococo's work include Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (10 papers) and Synthesis and Biological Evaluation (3 papers). Bruno Lococo is often cited by papers focused on Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (10 papers) and Synthesis and Biological Evaluation (3 papers). Bruno Lococo collaborates with scholars based in Argentina, United States and Czechia. Bruno Lococo's co-authors include Rodolfo Viotti, M Alvarez, Miriam Postan, Graciela Bertocchi, Alejandro Armenti, Carlos Vigliano, Marcos Petti, María C. Albareda, Susana A. Laucella and Rick L. Tarleton and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Bruno Lococo

13 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Lococo Argentina 9 927 751 227 181 131 13 960
María C. Albareda Argentina 15 810 0.9× 686 0.9× 195 0.9× 197 1.1× 96 0.7× 31 870
Alejandro Armenti Argentina 16 1.3k 1.4× 1.0k 1.3× 358 1.6× 230 1.3× 235 1.8× 25 1.4k
Marcos Petti Argentina 12 991 1.1× 726 1.0× 267 1.2× 156 0.9× 181 1.4× 16 1.1k
Graciela Bertocchi Argentina 18 1.3k 1.4× 1.0k 1.3× 358 1.6× 246 1.4× 218 1.7× 31 1.4k
Ana M. De Rissio Argentina 16 629 0.7× 466 0.6× 103 0.5× 142 0.8× 75 0.6× 25 668
Paulo López-Chejade Spain 8 652 0.7× 591 0.8× 119 0.5× 161 0.9× 38 0.3× 8 744
Andrade Sg Brazil 10 975 1.1× 779 1.0× 133 0.6× 225 1.2× 59 0.5× 23 1.0k
Shiromani Jayawardhana United Kingdom 13 539 0.6× 473 0.6× 235 1.0× 98 0.5× 16 0.1× 23 612
Anna Maria Simonsen Stolf Brazil 11 409 0.4× 317 0.4× 47 0.2× 103 0.6× 46 0.4× 24 458
Guillermo Moscatelli Argentina 14 527 0.6× 357 0.5× 153 0.7× 78 0.4× 57 0.4× 44 633

Countries citing papers authored by Bruno Lococo

Since Specialization
Citations

This map shows the geographic impact of Bruno Lococo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Lococo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Lococo more than expected).

Fields of papers citing papers by Bruno Lococo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Lococo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Lococo. The network helps show where Bruno Lococo may publish in the future.

Co-authorship network of co-authors of Bruno Lococo

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Lococo. A scholar is included among the top collaborators of Bruno Lococo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Lococo. Bruno Lococo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Albareda, María C., M Alvarez, Bruno Lococo, et al.. (2022). B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi–Specific Antibody-Secreting Cells Following Successful Etiological Treatment. The Journal of Infectious Diseases. 227(11). 1322–1332. 3 indexed citations
2.
Minning, Todd, María C. Albareda, M Alvarez, et al.. (2021). Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro. PLoS neglected tropical diseases. 15(6). e0009473–e0009473. 4 indexed citations
3.
Alvarez, M, Graciela Bertocchi, Marisa Fernández, et al.. (2015). New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients. Antimicrobial Agents and Chemotherapy. 60(2). 833–837. 63 indexed citations
4.
Albareda, María C., Damián Pérez‐Mazliah, M Alvarez, et al.. (2015). Perturbed T Cell IL-7 Receptor Signaling in Chronic Chagas Disease. The Journal of Immunology. 194(8). 3883–3889. 23 indexed citations
5.
Bertocchi, Graciela, Carlos Vigliano, Bruno Lococo, Marcos Petti, & Rodolfo Viotti. (2013). Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 107(6). 372–376. 30 indexed citations
6.
Albareda, María C., Gabriela C. Olivera, Susana A. Laucella, et al.. (2009). Chronic Human Infection with Trypanosoma cruzi Drives CD4+ T Cells to Immune Senescence. The Journal of Immunology. 183(6). 4103–4108. 80 indexed citations
7.
Laucella, Susana A., Graciela Bertocchi, M Alvarez, et al.. (2009). Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy. Clinical Infectious Diseases. 49(11). 1675–1684. 86 indexed citations
8.
Bertocchi, Graciela, M Alvarez, Alejandro Armenti, et al.. (2008). Evaluación inmunológica del tratamiento con benznidazol en la enfermedad de Chagas crónica. Redalyc (Universidad Autónoma del Estado de México). 76(4). 260–265. 3 indexed citations
9.
Bertocchi, Graciela, M Alvarez, Alejandro Armenti, et al.. (2008). Immunological Assessment of Benznidazole Therapy in Chronic Chagas Disease. 1 indexed citations
10.
Viotti, Rodolfo, Carlos Vigliano, Bruno Lococo, et al.. (2006). Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment. Annals of Internal Medicine. 144(10). 724–734. 443 indexed citations
11.
Laucella, Susana A., Miriam Postan, Diana L. Martin, et al.. (2004). Frequency of Interferon‐γ–Producing T Cells Specific forTrypanosoma cruziInversely Correlates with Disease Severity in Chronic Human Chagas Disease. The Journal of Infectious Diseases. 189(5). 909–918. 164 indexed citations
12.
Sosa‐Estáni, Sergio, Alejandro Armenti, Rodolfo Viotti, et al.. (2004). Tratamiento de Chagas con benznidazol y ácido tióctico. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 64(1). 1–6. 32 indexed citations
13.
Sosa‐Estáni, Sergio, Alejandro Armenti, Rodolfo Viotti, et al.. (2004). [Treatment of Chagas disease with benznidazole and thioctic acid].. PubMed. 64(1). 1–6. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026